{"id":205305,"name":"DRUG POLICY ACTION","slug":"drug-policy-action","state":"NY","country":"United States of America","description":"Drug Policy Action works to pass drug laws grounded in science, health, and human rights.","totalSpending":350000,"filings":15,"yearlySpending":[{"year":2020,"income":80000},{"year":2021,"income":80000},{"year":2022,"income":150000},{"year":2023,"income":40000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"LAW","display":"Law Enforcement/Crime/Criminal Justice"}],"firms":["COLLIER COLLECTIVE, LLC"],"lobbyists":["JENNY COLLIER","DANIELLE NEAL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Office of Natl Drug Control Policy (NDCP)","Substance Abuse & Mental Health Services Administration (SAMHSA)","Justice, Dept of (DOJ)"],"sampleDescriptions":["Create legal protection for overdose prevention centers through the FY21 appropriations process.","Create legal protection for overdose prevention centers through the FY21 Commerce, Justice, Science and Related agencies annual appropriations bill.","Advocate for COVID-19 relief for syringe services programs (SSPs) that provide overdose prevention and harm reduction services nationwide, including access to medical and behavioral health care, inclu","Create legal protection for overdose prevention centers through the FY21 Commerce, Justice, Science and Related agencies annual appropriations bill.","1.  Advocate for COVID-19 relief for syringe services programs (SSPs) and other harm reduction programs that provide overdose prevention and harm reduction services nationwide, including access to med"]}